Camp4 Therapeutics (CAMP) Return on Sales (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Return on Sales data on file, last reported at 0.09% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales rose 6.0% year-over-year to 0.09%; the trailing twelve-month figure through Mar 2026 stood at 0.15% (up 28.0% YoY), and the FY2025 full-year result was 0.36%, up 143.0% from the prior year.
• Return on Sales climbed to 0.09% in Q1 2026, from 0.37% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.09% in Q1 2026 to a low of 1.5% in Q2 2024.
• A 4-year average of 0.38% and a median of 0.2% in 2024 frame the typical range for Return on Sales.
• Peak annual rise in Return on Sales reached 136 bps in 2025, while the deepest fall reached 15 bps in 2025.
• Tracing CAMP's Return on Sales over 4 years: stood at 0.35% in 2023, then surged by 38 bps to 0.22% in 2024, then slumped by 70 bps to 0.37% in 2025, then jumped by 75 bps to 0.09% in 2026.
• Business Quant data shows CAMP's Return on Sales at 0.09% in Q1 2026, 0.37% in Q4 2025, and 0.18% in Q3 2025.